Alfuzosin thionol sulfoxide Smiles: CC1=CC(C(N)=O)=C(C=C1C(=O)N[C@H]1C[C@@H]2CC[C@H](C1)N2C1=CC=C(C=N1)C(=O)C1CC1)N[C@H](C)CC

Smiles: CC1=CC(C(N)=O)=C(C=C1C(=O)N[C@H]1C[C@@H]2CC[C@H](C1)N2C1=CC=C(C=N1)C(=O)C1CC1)N[C@H](C)CC

inducing selective G2/M cell-cycle arrest followed by apoptosis in a variety of tumor cells while causing reversible cell-cycle arrest at the G1 and G2 stages without apoptosis in normal cells

JSH-23 inhibits LPS and cytokine-induced nuclear translocation of the p65 subunit of NF-kB as analyzed by EMSA and western blot

Water: 36 mg/mL(199

17-31)20(26)9-12-28(21

Alfuzosin thionol sulfoxide Smiles: CC1=CC(C(N)=O)=C(C=C1C(=O)N[C@H]1C[C@@H]2CC[C@H](C1)N2C1=CC=C(C=N1)C(=O)C1CC1)N[C@H](C)CCAlfuzosin HCl is a pharmaceutical drug of the alpha 1 blocker class. As an antagonist of the alpha 1 adrenergic receptor, it works by relaxing the muscles in the prostate and bladder neck, making it easier to urinate. It is thus used to treat benign prostatic hyperplasia (BPH). Alfuzosin is marketed in the United States by Sanofi Aventis under the brand name Uroxatral and elsewhere under the tradename Xat or Xatral, and in Egypt under name of